Effect of zanamivir on duration and resolution of influenza symptoms

This publication has 15 references indexed in Scilit:

• Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study
  Journal of Infection, 2000
• Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies
  Antimicrobial Agents and Chemotherapy, 2000
• Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors
  Reviews in Medical Virology, 2000
• A novel approach to antiviral therapy for influenza.
  Journal of Antimicrobial Chemotherapy, 1999
• Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections
  The Journal of Infectious Diseases, 1999
• Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
  The Lancet, 1998
• Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
  New England Journal of Medicine, 1997
• Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
  New England Journal of Medicine, 1989
• Influenza: Quantifying morbidity and mortality
  The American Journal of Medicine, 1987
• Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic
  JAMA, 1985